Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)
Affymetrix Releases Comprehensive Validated Data From The Axiom™ Genomic Database

Affymetrix Releases Comprehensive Validated Data From The Axiom™ Genomic Database

Affymetrix, Inc. (NASDAQ: AFFX) today announced the release of a complete data set of 5 million variants on its website.

Affymetrix Announces Webcast Presentations From March Financial Conferences

Affymetrix Announces Webcast Presentations From March Financial Conferences

Affymetrix, Inc. (Nasdaq:AFFX) today announced that company management will provide a corporate overview at the following financial conferences in March.

Affymetrix® Launches Next-Generation MicroRNA Solution

Affymetrix® Launches Next-Generation MicroRNA Solution

Affymetrix, Inc. (NASDAQ:AFFX) today launched the GeneChip® miRNA 2.

Affymetrix Director Paul Berg To Retire

Affymetrix Director Paul Berg To Retire

Affymetrix, Inc. (NASDAQ: AFFX) today announced that Paul Berg, Ph.

Affymetrix(R) Anatrace(R) Brand NG Class(TM) Detergents, A New Family Of Detergents Based On The Maltose-neopentyl Amphiphile Design Found Superior For Integrative Membrane Proteins Study. (Graphic: Business Wire)

Affymetrix(R) Anatrace(R) Brand NG Class(TM) Detergents, A New Family Of Detergents Based On The Maltose-neopentyl Amphiphile Design Found Superior For Integrative Membrane Proteins Study. (Graphic: Business Wire)

Affymetrix, Inc. (NASDAQ:AFFX) today launched its Anatrace® brand Neopentyl Glycol (NG) Class™ Detergents, the next generation of detergents to significantly advance the study of integral membrane proteins (IMPs),...

Affymetrix CEO Discusses Q4 2010 Results - Earnings Call Transcript

Affymetrix CEO Discusses Q4 2010 Results - Earnings Call Transcript

Affymetrix CEO Discusses Q4 2010 Results - Earnings Call Transcript

Affymetrix Reports Fourth Quarter And Fiscal Year 2010 Results

Affymetrix Reports Fourth Quarter And Fiscal Year 2010 Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the fourth quarter and fiscal year ended December 31, 2010.

Affymetrix Provides Highest Density Rice Genotyping Array For Identifying Unique Genetic Traits

Affymetrix Provides Highest Density Rice Genotyping Array For Identifying Unique Genetic Traits

Affymetrix, Inc. (NASDAQ:AFFX) today announced at the Plant and Animal Genome XIX Conference (PAG) that it launched the GeneChip® Rice 44K SNP Genotyping Array, the first high-density rice genotyping array.

Axiom(TM) Genome-Wide BOS 1 Array, Developed In Conjunction With The Affymetrix Bovine Consortium Of Leading Breeders And Researchers Worldwide, Comprehensively Covers Genetic Traits From The Most Commercially Vital Breeds Of Dairy And Beef Cattle. (Photo: Business Wire)

Axiom(TM) Genome-Wide BOS 1 Array, Developed In Conjunction With The Affymetrix Bovine Consortium Of Leading Breeders And Researchers Worldwide, Comprehensively Covers Genetic Traits From The Most Commercially Vital Breeds Of Dairy And Beef Cattle. (Photo: Business Wire)

Affymetrix, Inc. (NASDAQ:AFFX) today announced it has launched the Axiom™ Genome-Wide BOS 1 Array, which has 34 percent higher genetic coverage than the current leading array because of its unique design.

The GeneAtlas(tm) System Brings The Power Of Affymetrix Microarrays To Every Researchers' Lab And Provides A Complete Personal Solution For Processing Affymetrix Microarrays. (Photo: Business Wire)

The GeneAtlas(tm) System Brings The Power Of Affymetrix Microarrays To Every Researchers' Lab And Provides A Complete Personal Solution For Processing Affymetrix Microarrays. (Photo: Business Wire)

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has signed a distribution agreement with Fisher Scientific, Inc.

Affymetrix Announces Positive Operating Income And Net Income For Q4-2010

Affymetrix Announces Positive Operating Income And Net Income For Q4-2010

Affymetrix, Inc. (NASDAQ:AFFX) today announced that based on preliminary financial data, the Company expects to generate positive operating income and net income on a GAAP basis for the fourth-quarter of 2010.

Affymetrix To Webcast Presentation At The 29th Annual JP Morgan Healthcare Conference

Affymetrix To Webcast Presentation At The 29th Annual JP Morgan Healthcare Conference

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will webcast the Company’s presentation at the 29th Annual JP Morgan Healthcare Conference on Thursday, January 13, 2011, at 7:30 a.

Affymetrix Announces Court Order Directing Dismissal Of Illumina Patent Infringement Lawsuits

Affymetrix Announces Court Order Directing Dismissal Of Illumina Patent Infringement Lawsuits

Affymetrix, Inc. (NASDAQ:AFFX) (the “Company”) today announced that the U.

Affymetrix To Webcast Presentation At The 22nd Annual Piper Jaffray Health Care Conference

Affymetrix To Webcast Presentation At The 22nd Annual Piper Jaffray Health Care Conference

Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company’s presentation at the 22nd Annual Piper Jaffray Health Care Conference on Wednesday, December 1, 2010, at 1:30 p.

Affymetrix To Provide Data Set Of Millions Of Genotypes To 1000 Genomes Project

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will contribute genotyping data for a large set of validated rare and common genomic variants to the 1000 Genomes Project.

Affymetrix CEO Discusses Q3 2010 Results - Earnings Call Transcript

Affymetrix CEO Discusses Q3 2010 Results - Earnings Call Transcript

Affymetrix CEO Discusses Q3 2010 Results - Earnings Call Transcript

Affymetrix Reports Third Quarter 2010 Results

Affymetrix Reports Third Quarter 2010 Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the third quarter of 2010.

Affymetrix Custom Arrays Enable Breakthrough Malaria Discoveries

Affymetrix Custom Arrays Enable Breakthrough Malaria Discoveries

Affymetrix, Inc. (NASDAQ: AFFX) announced today that an international team of researchers led by scientists at Boston College, the Broad Institute, and Imperial College London used an Affymetrix custom microarray to ...

Affymetrix To Host Conference Call On October 27, 2010 To Announce Third Quarter Results

Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will release operating results for the third quarter of 2010 after close of the stock market on Wednesday, October 27, 2010.

Affymetrix To Webcast Presentations At September Financial Conferences

Affymetrix, Inc. (Nasdaq:AFFX) today announced that company management will provide a corporate overview at four financial conferences in September.

Affymetrix To Commercialize Powerful Genotyping Array For Chinese Population

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will develop and commercialize the Axiom™ Chinese myDesign™ Genotyping Array, the first product that provides maximum power for genome-wide...

Affymetrix Releases Data From Validated SNP Database For Design Of Custom Genotyping Arrays

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has released an unparalleled data set based on extensive validation of novel SNPs from the 1000 Genomes Project.

Affymetrix, Inc. Q2 2010 Earnings Call Transcript

Affymetrix, Inc. Q2 2010 Earnings Call Transcript

Affymetrix Reports Second Quarter 2010 Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2010.

Affymetrix Ushers In New Era Of “In Situ Multiplex Gene Expression Analysis” With The Launch Of QuantiGene ViewRNA

Affymetrix Ushers In New Era Of “In Situ Multiplex Gene Expression Analysis” With The Launch Of QuantiGene ViewRNA

Affymetrix, Inc. (NASDAQ:AFFX) today announced the launch of QuantiGene® ViewRNA Assay formats, which enable a new era of “ in situ multiplex gene expression analysis” by allowing drug screening of native ...

Affymetrix Launches Axiom Custom Genotyping Arrays Utilizing World’s Largest Validated SNP Database

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has launched Axiom™ Custom Genotyping Arrays, the newest addition to the Axiom Genotyping Solution.

Bond Market Breakdown, Terremark CEO, Stocks Under $10

Bond Market Breakdown, Terremark CEO, Stocks Under $10

Gregg Greenberg breaks down today's market action with guests Manny Medina, CEO of Terremark, Tom Graff, RealMoney Contributor, and David Peltier, TheStreet's Stocks Under $10 portfolio manager.

Affymetrix Announces Preliminary Revenue For Second Quarter 2010

Affymetrix, Inc. (Nasdaq:AFFX) today reported that based on preliminary financial data, the Company expects total revenue for the second quarter of 2010 to be in the range of $71-72 million, as compared to the ...

Signature Diagnostics To Use Affymetrix Microarray Technology For Advanced Colorectal Cancer Tests

Affymetrix, Inc. (NASDAQ:AFFX) and Signature Diagnostics AG (Signature Dx) today announced that they have signed a Powered by Affymetrix™ (PbA) agreement.

Affymetrix To Webcast Presentation From Jefferies 2010 Global Life Sciences Conference

Affymetrix, Inc. (NASDAQ: AFFX) today announced the webcast of its presentation at the Jefferies 2010 Global Life Sciences Conference in New York City.